Novo Partnership Fuels Long-Term Optimism for Hims & Hers Health, Inc. (HIMS) [Yahoo! Finance]
Hims & Hers Health, Inc. Class A (HIMS)
Company Research
Source: Yahoo! Finance
Hims & Hers Health, Inc. (NYSE:HIMS) with a price target of $30. This reaffirmation comes after the company's launch of Novo Nordisk weight-loss solutions on its platform. First announced on March 9, the partnership involves access to Wegovy and Ozempic injections across all dosage levels on its platform. Canaccord Genuity highlighted that the revenue outlook appears challenged as the compounded-to-branded transition unfolds. Even then, the firm remains positive on Hims & Hers Health, Inc. (NYSE:HIMS) due to the Novo partnership, which it believes will contribute to the long-term growth momentum. Billion Photos/Shutterstock.com A day earlier, BofA Securities maintained a Neutral rating and a price target of $23 on Hims & Hers Health, Inc. (NYSE:HIMS). This follows the company's announcement related to its GLP-1 subscription service. The firm named many factors that create ambiguity, including whether a standalone margin exists for the medicine. That said, the firm views the comp
Show less
Read more
Impact Snapshot
Event Time:
HIMS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HIMS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HIMS alerts
High impacting Hims & Hers Health, Inc. Class A news events
Weekly update
A roundup of the hottest topics
HIMS
News
- CROX vs. CTAS: Which Stock Should Value Investors Buy Now? [Yahoo! Finance]Yahoo! Finance
- HIMS Investors Have Opportunity to Join Hims & Hers Health, Inc. Fraud Investigation with the Schall Law FirmGlobeNewswire
- Hims Data Breach Tests Trust As Valuation Gap Attracts Investors [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Health Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Hims & Hers Health, Inc. - HIMSBusiness Wire
- Hims & Hers' Valuations Back To Earth - Robust Monetization Trends Deserve Reiterated Buy [Seeking Alpha]Seeking Alpha
HIMS
Earnings
- 2/23/26 - Beat
HIMS
Sec Filings
- 4/10/26 - Form 4
- 4/7/26 - Form 4
- 4/6/26 - Form 144
- HIMS's page on the SEC website